DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)

作者： K. Lippuner , O. Torring , S. Minisola , C.L. Benhamou , S. Papapoulos